[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-352313-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-352313-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","deep-neural-network-based-biostatistical-analysis-for-disease-marker-screening-read-online-free","Deep neural network-based biostatistical analysis for disease marker screening - read online free","","Deep neural network methods address limitations of classical biostatistical approaches when screening disease biomarkers from high-dimensional, small-sample omics data. The study introduces a DNN-based biomarker screening framework and benchmarks it against methods such as LASSO and random forests on breast cancer datasets. Results emphasize improved sensitivity, accuracy, and AUC. To support clinical trust, the framework combines attention mechanisms with SHAP-based interpretability. It extends to multi-omics integration and explanatory power, validating performance on breast cancer single-cell sequencing and enabling scalable cross-disease precision medicine.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/deep-neural-network-based-biostatistical-analysis-for-disease-marker-screening-read-online-free/352313/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/deep-neural-network-based-biostatistical-analysis-for-disease-marker-screening-read-online-free/352313.png","ImageObject",300,407,{"name":42,"@type":43},"Eliana","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are traditional biostatistical methods limited for biomarker screening in this study?","Question",{"text":63,"@type":64},"Traditional methods are effective for low-dimensional data, but their expressive power and screening efficiency decrease when handling high-dimensional, small-sample omics with complex nonlinear patterns.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What models does the proposed framework compare against?",{"text":68,"@type":64},"The paper compares the deep neural network biomarker screening framework with traditional methods including LASSO and random forests.",{"name":70,"@type":61,"acceptedAnswer":71},"How does the study improve model interpretability for clinicians?",{"text":72,"@type":64},"It integrates an attention mechanism with SHAP value analysis to provide guided biological interpretations aligned with clinical decision-making needs.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},352313,1791088824,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":124,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},4398048949847,"https://ap-avatar.wpscdn.com/avatar/400002536579ef2da7f?_k=1778318612642679267","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nDeep neural network-based biostatistical analysis for disease marker screening  \nXinyi Wang  \nTraditional statistical methods have limitations when dealing with high-dimensional, small-sample data. Deep learning methods have attracted widespread attention due to their powerful feature learning capabilities. Leveraging deep neural networks (DNNs), this paper proposes a novel biomarker screening framework and compares it with traditional statistical methods such as Least Absolute Shrinkage and Selection Operator (LASSO) and random forests. Experiments conducted on a breast cancer dataset demonstrate the superiority of DNN models for biomarker screening, particularly in key metrics such as sensitivity, accuracy, and Area Under the Curve (AUC). To enhance the interpretability of the model, this paper combines an attention mechanism with SHapley Additive exPlanations (SHAP) value analysis, enabling the model to provide clinicians with more guided biological interpretations. The experimental results demonstrate that the DNN model can improve the accuracy of biomarker screening while exhibiting considerable interpretability and practical application potential. Although there are many biomarker screening studies using deep neural networks, this study is not just a simple repetition of existing work. Instead, it designs a scalable comprehensive model for multi-omics data integration and enhanced explanatory power. This framework performs well in the validation of breast cancer single-cell sequencing data. The framework has the potential for expansion in crossdisease applications and sets a practical example for the future development of cross-disease precision medicine.  \nKeywords Deep neural network (DNN), Biomarker screening, Precision medicine, SHAP value, Breast cancer, Feature selection, Attention mechanism  \nWith the rapid development of high-throughput omics technology, biomedical research has gradually entered anew data-driven stage. How to efficiently mine possible disease diagnostic markers from large-scale and complex biological data has become a core issue in precision medicine research. Conventional biostatistical analysis methods, such as descriptive statistics, analysis of variance, and logistic regression, have obvious advantagesin low-dimensional data processing and interpreting variable relationships. However, when dealing with highdimensional, small-sample omics data with complex nonlinear characteristics, their expressive power and screening efficiency are gradually limited.  \nDeep learning technologies, particularly deep neural networks (DNNs), are gradually transforming the research paradigm of bioinformatics with their exceptional capabilities for automatic feature extraction and nonlinear modeling. DNNs have achieved remarkable results in fields such as gene expression analysis, protein structure prediction, and medical image recognition, highlighting their enormous potential in disease prediction and biomarker screening. However, the direct application of DNNs in biomarker screening still faces several challenges, such as a lack of model interpretability and imperfect high-dimensional feature selection mechanisms. Therefore, it is necessary to promote innovation and integration in both theory and method.  \nThis paper aims to build a marker screening system that integrates biostatistical analysis and deep neural networks, fully integrating the robust advantages of classical statistical models with the expressive potential of deep learning, and improving the accuracy of disease diagnosis-related feature screening and its clinical application value. By introducing attention mechanisms, embedded feature selection methods and interpretability technologies, this study has achieved the operation of accurate marker screening, and also expanded the model’s ability to explain to medical experts, driving its transformation into a clinical deci","cbCaik0ARFqbwrHR","https://ap.wps.com/l/cbCaik0ARFqbwrHR","pdf",1872065,"English","# Deep learning for omics-based biomarker discovery and feature selection\n## Literature review and theoretical basis\n## Marker screening system integrating DNNs and biostatistics","[{\"question\":\"Why are traditional biostatistical methods limited for biomarker screening in this study?\",\"answer\":\"Traditional methods are effective for low-dimensional data, but their expressive power and screening efficiency decrease when handling high-dimensional, small-sample omics with complex nonlinear patterns.\"},{\"question\":\"What models does the proposed framework compare against?\",\"answer\":\"The paper compares the deep neural network biomarker screening framework with traditional methods including LASSO and random forests.\"},{\"question\":\"How does the study improve model interpretability for clinicians?\",\"answer\":\"It integrates an attention mechanism with SHAP value analysis to provide guided biological interpretations aligned with clinical decision-making needs.\"}]","Deep neural network-based biostatistical analysis for disease marker screening - read online free | PDF",1790098871,25,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/810a0334a0d968fb0c11d1b8bfe2dd77.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/656b942f887d3a16901676dbe2d5460b.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1d52a2d093d53b8e49dbd4deb765f22e.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cde67f2e3d9faf32090fc60a5a2d24a0.webp",980,1287]